中外製薬株式会社
Tokyo, Japan
Active| Registration number | T5011501002900 |
|---|---|
| Type | Corporation |
| Registered name | 中外製薬株式会社 |
| Address | 東京都北区浮間５丁目５番１号 5-5-1 Ukima, Kita-ku, Tokyo 115-0051, JAPAN |
| Corporate number | 5011501002900 |
| Corporate number assigned on | 2015-10-05 |
| Invoice registered on | 2023-10-01 |
Invoice registration date = when the T-number took effect, not the founding date.
Corporate registry record
| Entity type | Kabushiki Kaisha (stock company) |
|---|---|
| Representative | 代表取締役社長CEO 奥田 修 |
| Reading (furigana) | チュウガイセイヤク |
| Reading (romaji) | Chugaiseiyaku |
| English name (unofficial) | Chugai Pharmaceutical |
| Postal code | 115-0051 |
Source: NTA Corporate Number Publication Site, refreshed daily. Representative: gBizINFO (METI, monthly).
Company profile (gBizINFO)
| Business summary | 医薬品の研究、開発、製造、販売および輸出入 |
|---|---|
| Business lines | E:製造業 |
| Employees | 5,104 （male 3,410 / female 1,694） |
| Capital | ¥73.20B |
| Website | www.chugai-pharm.co.jp/ |
Source: gBizINFO (METI), refreshed monthly — edited extract by LoreaTec. Figures are as filed by each company.
Timeline — registry changes
| 2026-01-09 | Merger — absorbed another company |
|---|
Source: daily change files of the NTA Corporate Number Publication Site. Before 2023-08-16 only the latest change is known. All company events →
Government contract awards (GEPS)
No public national-government (GEPS) award records for this company in the open data (FY2013 to date).
出典：調達ポータル（https://www.p-portal.go.jp/）
Subsidies & grants received (gBizINFO)
2 published awards (2021-11-19 → 2021-11-19, 1 programme, total ¥711.3M).
| 2021-11-19 | 令和３年度（令和２年度からの繰越分）新型コロナウイルス感染症治療薬の実用化のための支援事業費国庫補助金 ¥458.1M （厚生労働省） |
|---|---|
| 2021-11-19 | 令和３年度（令和２年度からの繰越分）新型コロナウイルス感染症治療薬の実用化のための支援事業費国庫補助金 ¥253.1M （厚生労働省） |
Source: gBizINFO (METI) subsidy information, refreshed monthly. Amounts as published (grant decisions). Subsidies database →
Payments from national budget programmes (行政事業レビュー)
Ministry review sheets report this company as a payee of 1 programme (1 lines, sheet years 2025–2025; total ¥606.0M).
| 2025 FY2024 | 新型インフルエンザ等対策費 ¥606.0M （厚生労働省） 医薬品等買上費 |
|---|
Contract details (excerpt): 抗インフルエンザウイルス薬の購入 ¥606.0M・随意契約（その他） · bidders 1
Source: 行政事業レビュー見える化サイト (Cabinet Secretariat, PDL 1.0) — edited extract by LoreaTec. A sheet year describes the previous fiscal year’s spending. Programme database →
Licenses, registrations & certifications (gBizINFO)
| 2025-04-01 | DX Certification (METI) （METI） |
|---|---|
| 2023-04-01 | DX Certification (METI) （METI） |
| 2021-04-01 | DX Certification (METI) （METI） |
Source: gBizINFO (METI) notifications & certifications dataset, refreshed monthly. Some licenses (e.g. construction 建設業許可, electrician registrations) are not part of the gBizINFO dataset.
Verify in official sources
How to cite this page
Data via LoreaTec BizSearch (https://bizsearch.loreatec.jp/t5011501002900) — Source: National Tax Agency corporate-number and qualified-invoice registries. Retrieved 2026-11-09.
Reuse and AI use allowed with attribution. AI content licence